We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioFocus and Ono Sign a Drug Discovery Agreement in the Field of CNS Disorders

News   Oct 08, 2012

 
BioFocus and Ono Sign a Drug Discovery Agreement in the Field of CNS Disorders
 
 
 

RELATED ARTICLES

Mouse Study Reverses Sensory Impairment in Autism Model

News

Genetic technique is a step toward strategy to help people with autism better process visual cues

READ MORE

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

A Grand Plan to Target Cause of Alzheimer's Disease

News

A breakthrough has been made in the fight against Alzheimer's disease - researchers have found a new way to target the toxic particles that destroy healthy brain cells. Academics have devised the first strategy to 'go after' the cause of the devastating disease, leading to hope that new drugs could be developed to treat dementia.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE